Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
MOG extracellular domain (p1-125) triggers elevated frequency of CXCR3+ CD4+ Th1 cells in the CNS of mice and induces greater incidence of severe EAE.
How reliable is the classification of cognitive impairment across different criteria in early and late stages of multiple sclerosis?
Factors associated with clinically significant increased walking time in multiple sclerosis: Results of a survival analysis of short-term follow-up data from a clinical database.
The innate immune adaptor MyD88 is dispensable for spontaneous autoimmune demyelination in a mouse model of multiple sclerosis.
Repeated measurement of the attention components of patients with multiple sclerosis using the Attention Network Test-Interaction (ANT-I): Stability, isolability, robustness, and reliability.
Histone deacetylase gene variants predict brain volume changes in multiple sclerosis.
Peptidylarginine deiminase and protein citrullination in prion diseases: Strong evidence of neurodegeneration.
The Effect of Melatonin on Behavioral, Molecular, and Histopathological Changes in Cuprizone Model of Demyelination.
Retinoid X receptor activation reverses age-related deficiencies in myelin debris phagocytosis and remyelination.
Radiolabeling and in vitro / in vivo evaluation of N-(1-adamantyl)-8-methoxy-4-oxo-1-phenyl-1,4-dihydroquinoline-3-carboxamide as a PET probe for imaging cannabinoid type 2 receptor.
Primary CNS lymphoma masquerading as tumefactive demyelination.
Orientational ordering of carotenoids in myelin membranes resolved by polarized Raman microspectroscopy.
Immunotherapy using LPS-stimulated Bone Marrow-derived Dendritic Cells to Treat Experimental Autoimmune Encephalomyelitis.
Histological characterization and quantification of cellular events following neural and fibroblast(-like) stem cell grafting in healthy and demyelinated CNS tissue.
Dysregulation of the IL-23/IL-17 axis and myeloid factors in secondary progressive MS.
Multiple sclerosis: IgM bands indicate reduced risk of PML on natalizumab.
Differential patterns of spinal cord and brain atrophy in NMO and MS.
Alemtuzumab in multiple sclerosis: an update.
Acute disseminated encephalomyelitis followed by recurrent or monophasic optic neuritis in pediatric patients.
New drug for relapsing multiple sclerosis.
Restless Legs Syndrome in Multiple Sclerosis.
Prevalence of multiple sclerosis in Verona, Italy: an epidemiological and genetic study.
Images in clinical medicine. Bilateral internuclear ophthalmoplegia in multiple sclerosis.
High-mobility group box 1 protein (HMGB1) neutralization ameliorates experimental autoimmune encephalomyelitis.
Gut dysfunction in patients with multiple sclerosis and the role of spinal cord involvement in the disease.
Pages
« first
‹ previous
…
330
331
332
333
334
335
336
337
338
…
next ›
last »